Shanghai InnoStar Bio-tech Co (688710.SS) Stock Price

Shanghai InnoStar Bio-tech Co Price

CLOSED
99.80
​
Market closed

Over the last 4 years Shanghai InnoStar Bio-tech Co grew revenue by 8.9% annually, reaching 802.71 M CNY. Earnings per share have grown at 19.4% per year over the last 3 years. For Shanghai InnoStar Bio-tech Co, the net margin of -3.8% is down versus 15.2% a few years ago. At today's price the dividend yield works out to roughly 0.32%.

Shanghai InnoStar Bio-tech Co stock price

Access this data via the Eulerpool API

Shanghai InnoStar Bio-tech Co business model & stock analysis

Shanghai InnoStar Bio-tech Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Shanghai, Shanghai and currently employs 1,085 full-time employees. The company went IPO on 2024-09-03. Shanghai InnoStar Bio-tech Co Ltd is a China-based company that mainly provides biopharmaceutical non-clinical research services. The firm's services mainly cover early drug development evaluation of biopharmaceuticals, non-clinical research, and clinical testing and translational research. The early drug development evaluation of biopharmaceuticals develops multiple early toxicity rapid prediction and screening models. The clinical testing and translational research business mainly provides analytical methods and data support for the clinical pharmacokinetics, efficacy, and safety research of innovative drug projects. The non-clinical research section specifically includes non-clinical safety evaluation, non-clinical pharmacokinetic research, and non-clinical pharmacodynamic research.

Frequently asked questions about Shanghai InnoStar Bio-tech Co

5 analysts currently rate the Shanghai InnoStar Bio-tech Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Shanghai InnoStar Bio-tech Co to generate revenue of 1.39 B CNY and earnings per share of 1.40 CNY.

Converted at the current exchange rate, the Shanghai InnoStar Bio-tech Co share trades at 13.29 EUR (99.80 CNY).

The expected revenue of Shanghai InnoStar Bio-tech Co is 1.39 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Shanghai InnoStar Bio-tech Co is 197.92 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Shanghai InnoStar Bio-tech Co is currently 71.09. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Shanghai InnoStar Bio-tech Co stock.

The price-to-sales ratio (P/S) of Shanghai InnoStar Bio-tech Co is currently 10.14. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Shanghai InnoStar Bio-tech Co stock.

The Eulerpool Quality Score for Shanghai InnoStar Bio-tech Co is 1/10.

The ISIN of Shanghai InnoStar Bio-tech Co is CNE1000078J7. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Shanghai InnoStar Bio-tech Co is 688710.SS. The ticker symbol is used to trade Shanghai InnoStar Bio-tech Co shares on the stock exchange.

Fair ValueTerminal
100.80 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue per Employee
739,825.53 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website innostar.cn
Country
Currency
CNY
Initial public offering
Sep 3, 2024
ISIN
CNE1000078J7
Cusip
Y768TY109
Market capitalization
14.07 B CNYLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
71.09
P/Se
10.14
EV/EBIT
615.08
P/B Ratio
6.06
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-1.31 %
Dividend
Dividend yield
0.32 %
Est. Dividend Yield
0.32 %
Payout Ratio
-147.84 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
1 year
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
10.00 %
Last updated Oct 10, 2026, 10:08 PM

Shanghai InnoStar Bio-tech Co Peer Group